Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Xontogeny
Biotech
Perceptive unveils $515M fund, its 2nd for early-stage biotechs
Dubbed the Perceptive Xontogeny Fund II, the capital will bankroll series A rounds of $20 million to $40 million for life sciences companies.
Amirah Al Idrus
May 12, 2021 6:55am
'Gene therapy engine' Forge debuts with $40M, Tim Miller as CEO
Jul 21, 2020 7:01am
Perceptive allies with Garabedian on $210M early-stage fund
Dec 10, 2019 9:32am
